Rocket Pharmaceuticals’ Post

Last week, Dr Catherine Beech MB,ChB,OBE sat down with Julie Schlosser (Lexitas Pharma Services) for the latest episode of the 'In Focus' #podcast. In this episode, Catherine and Julie explore the science that underpins Exonate's technology, the recent clinical trial success of EXN407, and how this technology is poised to revolutionize #ophthalmology treatments. Listen to the full episode here: https://rb.gy/y9axyr

check out this podcast with Catherine Beech MB,ChB,OBE!

#podcast Cynthia Pussinen, CEO of Sernova, describes their innovative cell therapy platform, the Cell Pouch System, which can deliver functional cures for chronic diseases using therapeutic cells, tissues, proteins, and other molecules. This implantable device is made of mesh that allows for vascularization, forming a pseudo-organ that can function in the body and fulfill unmet needs. The current focus is on type one diabetes, where the Cell Pouch has shown promising results, allowing patients to become insulin-independent. Other potential applications include treating hypothyroidism and hemophilia A. #FunctionalCure #CellTherapy #ChronicDiseases #PrecisionMedicine #Medtech Sernova.com https://lnkd.in/gUUmQN6z

Preparing for a launch is a high-stakes gamble for biopharma. This is particularly true for companies focused on rare diseases, where patient groups are harder to find and HCPs could cross several specialties. In this episode, Andy Eeckhout of ADVANZ PHARMA speaks to Florian Schnappauf about how to tackle this ultimate challenge. As Andy explains, deep data and reference data can significantly improve the odds of lifting off after launch, and help MSLs get up-to-speed quickly for a deep scientific discussion with #KOLs. #lifesciences #WhatPharmaNeedsNext #podcast Watch or listen to the full episode here: https://bit.ly/46DdLLT

#LupusAwarenessMonth Take time to listen to this podcast!

Episode 9 of our Trail Blazers series is now live! 📽   On this episode we chat to Elena Mills about her journey with The Salve and the transformative power of embracing the B-Corp framework. Join us as we dive into the pharmaceutical landscape with Johnny and Elena, discussing the urgent need for investment in horizon scanning, especially concerning neglected diseases. You can catch the full episode here: https://lnkd.in/e_99JdzV #trailblazers #medicalpodcast #podcast #bcorp #pharmaceuticallandscape

Research trying to understand the earth-shaking COVID-19 pandemic continues. Here are three preprints from our free coronavirus preprints RSS feed: 1) The EU’s role in restructuring post-crisis global governance This policy paper addresses the European Union’s (EU) role in restructuring global governance in the aftermath of two significant crises: the COVID-19 pandemic and the Russian invasion of Ukraine. https://lnkd.in/gwywCacd 2) SARS-CoV-2 infection unevenly impacts metabolism in the coronal periphery of the lungs Infected peripheral lung tissue was characterized by lower levels of fatty acids and amino acids when compared to central lung tissue. This study highlights the spatial impacts of SARS-CoV-2 and helps explain why peripheral lung tissue is most damaged by COVID-19. https://lnkd.in/guUN-dVZ 3) Starve a cold or feed a fever? Identifying cellular metabolic changes following infection and exposure to SARS-CoV-2. We identified significant changes in metabolic pathways that correlate with either productive or non-productive viral infection. This information is critical for characterizing the factors that contribute to SARS-CoV-2 replication that could be targeted for therapeutic interventions to limit viral disease. https://lnkd.in/gu6quuTX

Check out our new podcast series "In Case You Missed… Year in Review- Uncontrolled Gout: Updates on the Latest Management Strategies" with Drs. Suneet Grewal, MD, Puja Khanna, and Michael Pillinger!   In "Burden and Complications of Uncontrolled Gout," our experts discuss key findings presented during the past year on disease burden and comorbidities associated with uncontrolled gout.   In "Evidence-Based Tools to Detect and Assess Uncontrolled Gout," our experts discuss key findings presented during the past year on evidence-based tools for detection and assessment of uncontrolled gout.   In "Recent Updates on Management of Uncontrolled Gout," our experts discuss key findings presented during the past year on current and emerging therapies for managing uncontrolled gout.   Find the series here: https://lnkd.in/ekVdM_XD

https://lnkd.in/dF32kuYB 🎧🔥 Get ready for an enlightening listen with Episode 5 of the Medical Associates Podcast! 🔥🎧 In this episode, we're tackling the important topic of prostate diseases, bringing you expert insights and essential information to help you stay informed and proactive about your health. Don't miss out on this valuable discussion, filled with tips, advice, and in-depth analysis from our knowledgeable hosts and guests. Be sure to check out our YouTube page 📺, where you can watch full episodes packed with even more information and engaging content. Plus, you can now find us on Spotify! 🎶 So no matter where you are or how you prefer to listen, we've got you covered. Don't let prostate diseases catch you off guard. Tune in to Episode 5 of the Medical Associates Podcast and join the conversation today! 🌟 #MedicalAssociatesPodcast #ProstateDiseases #StayInformed #ExpertInsights Reply in a thread

In our recent podcast session- HealthSpeak with MDForLives, we invited Nick Fontanella, who shared his views on how genetic variations influence medication responses. He also emphasized the need to move away from assumptions-based prescriptions towards a personalized approach to prescribing medication. Dr. Fontanella's insights underscored the potential of pharmacogenomics to optimize patient outcomes and revolutionize medication management practices. #MDForLives #Pharmacogenomics #PersonalizedMedicine #GeneticResearch #MedicationManagement #HealthTech #PrecisionMedicine #GeneticVariations #MedicalInnovation #PatientCare #FutureOfMedicine #HealthPodcast #PaidSurveys #HealthcareSurveys